Haematology / Oncology
The Section of Haematology / Oncology runs the Haematology Subspecialty Education Program as well as the Oncology Subspecialty Education Program.
The Section of Haematology/Oncology, within the Department of Internal Medicine, Max Rady College of Medicine, in affiliation with CancerCare Manitoba (CCMB) as the Department of Medical Oncology and Haematology, CCMB, is a research-oriented group that offers comprehensive care to adults in Manitoba with cancer and serious blood disorders. The Section consists of 34 full-time and 5 part-time faculty members, of whom 25 are Assistant Professor, 9 Associate, and 5 full Professors. Included in our team are 3 Physician Assistants (PAs), 8 Clinical Assistants (CAs), and 5 Nurse Practitioners (NPs). Our ambulatory care clinical services are based at 3 CancerCare Manitoba sites in Winnipeg (MacCharles/HSC, St Boniface, Victoria Hospitals), while in-patient services are at Saint Boniface Hospital and Health Sciences Centre, the latter including a unit dedicated to complex haematological malignancy and Blood and Marrow Transplantation [BMT].
We offer two distinct undergraduate courses at the Max Rady College of Medicine; Blood/Immunology and Medical Oncology. We provide Royal College of Physicians and Surgeons of Canada (RCPSC) accredited residency training programs in both Haematology and Medical Oncology, and also offer advanced (post-residency) training in sub-specialties such as BMT, lymphoma, and thoracic malignancy. In conjunction with CancerCare Manitoba’s Community Cancer Program, our Section members lead annual continuing professional development (CPD) sessions for primary care practitioners and specialists such as the Community Cancer Program Annual Meeting, Blood Disorders Day and a Geriatric Oncology Day.
The Section’s research portfolio is broad, with approximately $10.8 Million in active research funding, some 65 peer-reviewed publications per year, and a total of 6.5 physician Full-Time Equivalent (FTE) dedicated to research. We participate in clinical trials and we lead translational research, and cancer epidemiology and health outcomes programs through our partnership with CCMB’s Research Institute in Haematology/Oncology and the provincial Cancer Registry. High profile research interests include: Chronic Lymphocytic Leukemia (CLL), for which there is an active tumor bank and patient registry; Acute Care Haematology, in which there is close collaboration with Critical Care partners; studies of the pathogenesis, treatment and prevention of infections in vulnerable cancer patient populations; BMT registry outcomes, based on the Canadian BMT registry that is housed at CCMB.
Section members hold major leadership positions within both Canadian and International organizations, such as the Canadian Partnership Against Cancer (CPAC), pCODR (Pan-Canadian Oncology Drug Review), CBMTG (Canadian Blood and Marrow Transplant Group), ISBER (International Society for Biological and Environmental Repositories), RCPSC, the Infectious Diseases Society of America (IDSA), and ASH (American Society of Haematology).
